Health Industry Shake-Up: From Celebrity Backed Supplements to Genetic Drug Responses and Legal Verdicts
Published on: April 12, 2026, 6:31 p.m. | Source: Devdiscourse
Major health news highlights include AG1 potentially exploring a sale, linking genetic variations to the efficacy of GLP-1 drugs, FDA's refusal to approve Replimune's skin cancer treatment, and a jury ordering Abbott to pay $70 million over preterm infant formula allegations.
